|
Volumn 8, Issue 11, 2001, Pages 604-608
|
Changes in cellular immunity during chemotherapy for testicular cancer
|
Author keywords
Cellular immunity; Chemotherapy; Natural killer cell activity; Neutrophil activity; Testicular cancer
|
Indexed keywords
BLEOMYCIN;
CD16 ANTIGEN;
CD56 ANTIGEN;
CHROMIUM 51;
CISPLATIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
ARTICLE;
BACTERICIDAL ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CELL COUNT;
CELL FUNCTION;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
COLONY FORMING UNIT;
CONTROLLED STUDY;
FLOW CYTOMETRY;
GERM CELL TUMOR;
HUMAN;
LYMPHOCYTE;
MALE;
NATURAL KILLER CELL;
NEUTROPHIL;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
TESTIS CARCINOMA;
TREATMENT OUTCOME;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CARCINOMA, EMBRYONAL;
CHORIOCARCINOMA;
CISPLATIN;
ETOPOSIDE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
IMMUNITY, CELLULAR;
LEUKOCYTE COUNT;
MALE;
NEUTROPHILS;
SEMINOMA;
TESTICULAR NEOPLASMS;
|
EID: 0035660622
PISSN: 09198172
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1442-2042.2001.00392.x Document Type: Article |
Times cited : (13)
|
References (25)
|